Cargando…

Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE

SIMPLE SUMMARY: Research into the causes and potential treatments for cancer-related cognitive impairment has increased greatly over the past several years. Advances have been made in studies related to human neuropsychology and animal models of behavior. Findings from both types of studies implicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Harvey R., Varma, Ashima, Flowers, Sarah A., Rebeck, George William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766535/ https://www.ncbi.nlm.nih.gov/pubmed/33352780 http://dx.doi.org/10.3390/cancers12123842

Ejemplares similares

3367 A Mouse Model of APOE Genotype in Chemotherapy Related Cognitive Impairment
por: Demby, Tamar, et al.
Publicado: (2019)

The Synergistic Effects of APOE Genotype and Obesity on Alzheimer’s Disease Risk
por: Jones, Nahdia S., et al.
Publicado: (2018)

ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
por: Lanfranco, Maria Fe, et al.
Publicado: (2020)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

High-fat diet increases gliosis and immediate early gene expression in APOE3 mice, but not APOE4 mice
por: Jones, Nahdia S., et al.
Publicado: (2021)

APOE2 is associated with longevity independent of Alzheimer’s disease
por: Shinohara, Mitsuru, et al.
Publicado: (2020)

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
por: Tai, Leon M, et al.
Publicado: (2014)

Vascular biomarkers and ApoE4 expression in mild cognitive impairment and Alzheimer's disease
por: Oviedo, Diana C., et al.
Publicado: (2018)

Chemotherapy promotes astrocytic response to Aβ deposition, but not Aβ levels, in a mouse model of amyloid and APOE
por: Ng, Christi Anne S., et al.
Publicado: (2022)

Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE ε4, and Cognitive Impairment
por: Therriault, Joseph, et al.
Publicado: (2021)

Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease
por: Tamboli, Irfan Y., et al.
Publicado: (2014)

Metabolic Disturbances of a High-Fat Diet Are Dependent on APOE Genotype and Sex
por: Jones, Nahdia S., et al.
Publicado: (2019)

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
por: Martínez, Manuel Fernández, et al.
Publicado: (2009)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

Similarities and differences in structure, expression, and functions of VLDLR and ApoER2
por: Reddy, Sunil S, et al.
Publicado: (2011)

The generation and function of soluble apoE receptors in the CNS
por: Rebeck, G William, et al.
Publicado: (2006)

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease
por: Apostolova, Liana G., et al.
Publicado: (2014)

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
por: Qian, Jing, et al.
Publicado: (2017)

Influence of APOE Genotype on Mortality and Cognitive Impairment
por: Robinson, Andrew C., et al.
Publicado: (2020)

Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer’s Disease
por: Mosca, Alessandra, et al.
Publicado: (2018)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
por: Löwe, Luise Christine, et al.
Publicado: (2016)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
por: Fernández-Calle, Rosalía, et al.
Publicado: (2022)

Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice
por: Moser, V. Alexandra, et al.
Publicado: (2017)

Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOEε4 Allele
por: Gamarra, David, et al.
Publicado: (2015)

A polygenic risk score for Alzheimer’s disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic/Latino adults in the U.S.
por: Sofer, Tamar, et al.
Publicado: (2023)

Apo E4 Alleles and Impaired Olfaction as Predictors of Alzheimer’s Disease
por: Misiak, Magdalena M, et al.
Publicado: (2017)

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
por: Lim, Y Y, et al.
Publicado: (2015)

ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro
por: Nwabuisi-Heath, Evelyn, et al.
Publicado: (2014)

Lifestyle Complexity and Dementia Risk: Examining Moderation by APOE Genotype and Mild Cognitive Impairment
por: Moored, Kyle, et al.
Publicado: (2020)

Factors Influencing Alzheimer’s Disease Risk: Whether and How They are Related to the APOE Genotype
por: Zhang, Rong, et al.
Publicado: (2022)

Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ɛ4 carriers: a case–control study
por: Fernández-Martínez, Manuel, et al.
Publicado: (2013)

Influence of ApoE Genotype and Clock T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer’s Disease in Subjective Cognitive Decline and Mild Cognitive Impairment Patients
por: Bessi, Valentina, et al.
Publicado: (2020)

APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease
por: Zhou, Qin, et al.
Publicado: (2014)

Subjective cognitive decline, APOE ε4, and incident mild cognitive impairment in men and women
por: Müller-Gerards, Diana, et al.
Publicado: (2019)

Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition
por: Rodriguez, Gustavo A, et al.
Publicado: (2014)

Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
por: Qian, Jing, et al.
Publicado: (2021)

Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
por: Pillai, Jagan A., et al.
Publicado: (2021)

APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
por: Mirza, Saira Saeed, et al.
Publicado: (2019)

Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives
por: Najar, Jenna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3vmjr0qds327jqf4ee45er3mkt